reported on 14 children with hemoglobinopathies transplanted with αβT/CD19-depleted grafts or CD34 selected without an addback using a conditioning regimen with busulfan, thiotepa, cyclophosphamide, and antithymocyte globulin. Here, CD19 is linked to hemoglobinopathy.